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Background: The formulation and implementation of national ethical regulations to protect research participants is
fundamental to ethical conduct of research. Ethics education and capacity are inadequate in developing African
countries. This study was designed to develop a module for online training in research ethics based on the
Nigerian National Code of Health Research Ethics and assess its ease of use and reliability among biomedical
researchers in Nigeria.
Methodology: This was a three-phased evaluation study. Phase one involved development of an online training
module based on the Nigerian Code of Health Research Ethics (NCHRE) and uploading it to the Collaborative
Institutional Training Initiative (CITI) website while the second phase entailed the evaluation of the module for
comprehensibility, readability and ease of use by 45 Nigerian biomedical researchers. The third phase involved
modification and re-evaluation of the module by 30 Nigerian biomedical researchers and determination of
test-retest reliability of the module using Cronbach’s alpha.
Results: The online module was easily accessible and comprehensible to 95% of study participants. There were
significant differences in the pretest and posttest scores of study participants during the evaluation of the online
module (p = 0.001) with correlation coefficients of 0.9 and 0.8 for the pretest and posttest scores respectively. The
module also demonstrated excellent test-retest reliability and internal consistency as shown by Cronbach’s alpha
coefficients of 0.92 and 0.84 for the pretest and posttest respectively.
Conclusion: The module based on the Nigerian Code was developed, tested and made available online as a
valuable tool for training in cultural and societal relevant ethical principles to orient national and international
biomedical researchers working in Nigeria. It would complement other general research ethics and Good Clinical
Practice modules. Participants suggested that awareness of the online module should be increased through
seminars, advertisement on government websites and portals used by Nigerian biomedical researchers, and
incorporation of the Code into the undergraduate medical training curriculum.
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The potentials of research to contribute to improvement in
health may be surpassed by the magnitude of risk to partici-
pants, communities and local researchers. Consequently,
systematic ethical regulation of research is put in place to
ensure that research is conducted in a manner that maxi-
mizes benefits while minimizing harms to research partici-
pants. The National Bioethics Advisory Council in USA,
the Council of International Organization of Medical
Sciences (CIOMS) and the Nuffield Council of Bioethics
suggested that this situation needs initial and continuing
education in the ethics and science of biomedical and be-
havioral research for investigators, members of the
Research Ethics Committees (RECs), and sponsors of
research [1-3]. Several studies have shown that research
ethics training improves ethical conduct of research and
capacity for dealing with ethical dilemmas [4-6]. Hitherto,
researchers in low and middle income countries (LMIC)
including Nigeria have had limited access to training in
research ethics due to weak educational, social, economic
and health resources however there has been significant
investment in ethics education in the last two decades with
resulting improvements in ethics capacity building [7,8].
The design and implementation of ethically and scienti-
fically valid research in any country should be guided by a
set of rules and regulations based on global ethical princi-
ples but domesticated within local laws, regulations and
culture. It is against this background that the National
Health Research Ethics Committee in Nigeria (NHREC)
developed and formulated National Code for Health
Research Ethics (NCHRE) in August 2007 to guide all
researchers involved in human subjects’ researches in
Nigeria [9]. This Code reflects the collective concern of the
government and the people of Nigeria to ensure the pro-
tection of human participants in scientific research to the
highest ethical standard that is possible. It serves as the
basis for the operations of all institutional research ethics
committees in the country thus allowing for uniformity
and consistency. The Code is based on universal ethical
principles, historical ethical guidelines, existing regulations
from different countries, results of modern bioethics
research, Nigerian constitution, laws, regulations and go-
vernment guidelines as well as Nigerian custom and
practices.
Examples of peculiarities of the Code include conduct of
clinical trials in the country which requires approval from
the National Agency for Food and Drug Administration
(NAFDAC) and the emphasis on community engagement
in research in view of the country’s traditional communi-
tarian ethos. Every scientist involved in human subject
research in Nigeria, their sponsors and other stakeholders
must function within the scope of the National Health
Research Ethics Code. This demands that researchers be
aware and educated on the code with the anticipation thatthe knowledge of the guidelines would translate to its
practice in conduct of health-related research.
It is therefore appropriate to develop an educational tool
that will facilitate the understanding and implementation
of the Nigerian Code among stakeholders. An important
avenue for the facilitation of training in research ethics is
the provision of online courses [10,11]. Such online courses
can be accessed at different institutions in the country and
can be effective training tool in research ethics. It will also
be of immense benefit to all research ethics committees in
the country as it will facilitate education of their members
thus empowering them to effectively perform their roles in
the protection of human subjects guided by the NCHRE.
Furthermore international researchers and foreign spon-
sors would have easy access to the code which will
enlighten them on the ethical requirements for conducting
research in Nigeria. There are few studies that have
assessed the utility of online modules as ethics training
tools in improving knowledge and skills in health research
especially in resource poor settings.
It is against this background that this project was con-
ceived and designed with the objectives of developing an
online educational module based on the Nigerian Code
to enlighten biomedical researchers on the requirements
of conduct of ethically acceptable research in Nigeria
and evaluate its reliability in achieving this objective.Methodology
This was a prospective quantitative three phased study.
During phase one, we developed an online training mo-
dule based on the contents of the NCHRE and upload it
to the Collaborative Institutional Training Initiative
(CITI) website.
The Nigerian Code is a 68 page document with fifteen
main sections (Sections A to O) and one Appendix (with
sub-sections 32 to 34) [9]. Because the emphasis of the
online module is on ethical requirements for research in
Nigeria while avoiding repetition of general ethical guide-
lines which are already available on the CITI IRB module,
we compared the Nigerian Code with thirteen major
ethical guidelines, namely; Nuremberg Code [12], Belmont
Principle [13], Helsinki Declaration [14], CIOMS [2],
United States National Bioethics Advisory Council [1],
World Health Organization-Good Clinical Practice [15],
World Health Organization- operational guidelines for
ethics committees [16], Common Rule – 46 Code of
Federal Regulations (CFR) [17], Nuffield Council on Bio-
ethics [3], United Nations AIDS guidance on HIV preven-
tive vaccine research [18], Europeans Medicine Agency –
International Committee on Harmonization [19], Opinion
of European Group on ethics in science [20] and Directive
2001 [21] and isolated unique elements of the Nigerian
Code. These extracted contents formed the material
Ogunrin et al. BMC Medical Ethics 2013, 14:1 Page 3 of 17
http://www.biomedcentral.com/1472-6939/14/1content used to develop our training module (see Appendix
A. Annex 1).
The module consisted of 2 parts, an introductory part
which enumerated the genesis of the Code and its signifi-
cance to Nigeria, and the core educational part. The core
part contained information on registration of ethics com-
mittees, conducting research in institutions without ethics
committees, functions and operations of the health re-
search ethics committees, the informed consent process,
the health research ethics committee records, continuing
ethics training, disciplinary actions against those who vio-
late the Code, the national HREC oversight functions,
clinical trials agreement, materials transfer agreement, and
other regulatory agencies in Nigeria: including National
Agency for Food and Drug Administration and Control
(NAFDAC), institutional bio-safety committees, data and
safety monitoring board and community advisory board.
These elements from the Nigerian Code were thereafter
re-written and arranged carefully while ensuring that they
did not lose their meanings and interpretations, in the
CITI format to make the uploading unto the CITI web site
easier. The module was reviewed by two experienced
bioethicists who made recommendations on how to
improve its presentation without losing the originality of
the Code and the revised module was sent to the Director
of the CITI for uploading unto the CITI website as a
preliminary training module.Selection of participants
Forty five research participants were identified purpos-
ively and selected by convenience sampling from among
senior residents and consultants at the University of
Benin Teaching Hospital, Benin, Nigeria, as well as re-
search assistants and medical officers involved in the
Presidential Emergency Plan For AIDS Relief (PEPFAR)
program at the Institute for Human Virology Nigeria
(IHVN), University of Benin Teaching Hospital and
Masters of Public Health (MPH) program trainees of the
Center for Disease Control, Department of Community
Health, University of Benin. All participants had been
involved in human subjects’ research. These participants
voluntarily consented to participate in the research hav-
ing received detailed information on what the research
was about, what was expected of the participants, the
cost to the participant (in terms of time spent to
complete the study), expected duration of the task to be
performed by the participant, any possible risk (i.e. con-
fidentiality) and anticipated benefits (i.e. knowledge of
the Nigerian Code and the award of a certificate on
completion of module), incentive to participants (i.e.
refreshments during the study), the fact that any of the
participants could withdraw from the research at any
stage and the address/phone contact of the researcher.Evaluation of module
The study participants were allowed to choose a conveni-
ent day in the week when they had sufficient time to com-
mence and complete the study. They were divided into
three groups based on the day chosen for the pilot testing
of the online module and gathered in a relatively spacious,
quiet and comfortable room. They were instructed on
how to register on the CITI home page, complete the
pretest, study the online module and complete the post-
test. For new users, access to the module was facilitated by
logging onto www.citiprogram.org and clicking ‘New Users
– Register Here’ on the home page. The West African
Bioethics Program was selected as training institution in
step 1 of the registration procedure and admin@westafri-
canbioethics.net was entered as the institutional electronic
mail address in step 2. On submission of the registration
page, a new webpage appeared with the question, ‘Are you
conducting human subjects’ research in Nigeria? If you
are conducting research in Nigeria, you are required to
complete the NIGERIAN NATIONAL CODE FOR
HEALTH RESEARCH ETHICS Module’. Access to the
module page was granted by indicating ‘YES’. Once regis-
tration was completed, subsequent access to the module
on CITI home page was obtained by entering username
and password.
Each participant thereafter completed the module as
instructed. The time taken to study the online module
was noted. They were given refreshments during the
period of undertaking the study as compensation.
The online module was tested and evaluated for read-
ability and comprehensibility by the 45 study partici-
pants during the second phase. The pre-test was a
general quiz of multiple choice, true/false 9 questions to
test the knowledge of the Code and was administered on
paper. The post-test was completed online by the parti-
cipants and the scores were automatically generated. A
survey, with the aid of a questionnaire, was then con-
ducted after the post-test to assess the comprehensibility
and the ease of use of the online module, and any other
comments on how to improve it were obtained from the
study participants. The participants were requested to
choose from three options, namely; a) easily accessible
or comprehensible, b) difficult to access or comprehend,
and c) not accessible or comprehensible. Thereafter the
online module was revised based on the suggestions
obtained from the survey.
The third phase involved the evaluation of the revised
online module. Another set of study participants com-
prising fifteen participants from the first group and fif-
teen who did not participate in the initial evaluation
assessed the revised module using the same procedure
utilized in Phase Two by completing the pretest and
posttest on the revised version of the online module.
The test performances of the participants in this phase
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pants in phase two to determine the test-retest reliability
of the module.
Ethical approval
This study protocol was approved by the ethics review
committee of the University of Benin Teaching Hospital,
Benin City Nigeria. Informed consents were obtained
from all research participants. Identifiers were omitted
to ensure confidentiality and right of privacy of respon-
dents in line with the ethical principle of autonomy and
respect of persons.
Data management and analysis
The data was recorded in a password protected data-
base, and analysis was done with Stata version SE 10.0
(Stata Corp, USA). The scores from the pre and post
tests were analyzed for difference in performance using
appropriate statistics for hypothesis testing namely;
paired t test (to assess if there was significant difference
in means of performances) and correlation coefficients
(Pearson product moment). The level of confidence was
taken as p values < 0.05. The effects of the demographic
variables i.e. sex, age and specialty on pretest and postt-
est scores were assessed for statistical significance using
the likelihood-ratio chi-square analysis. The test-retest
reliability of the module was estimated using the Cron-
bach’s alpha as a measure of internal consistency which
ranges from 0 to 1.00. The acceptable level of reliability
was 0.80 or higher [22].
Results
Demographic details of phase two study participants
Forty five biomedical researchers participated in the ini-
tial evaluation of the online module. The participants
comprised eighteen females and twenty seven males with
a mean age of 35.72 years (SD 3.36) and a range of 25.5
to 45.5 years. The demographic details are as shown in
Table 1. Fifteen of the participants were senior resident
doctors; seventeen were MPH trainees from diverse
backgrounds of health-related practices, nine consul-
tants, two research fellows and two research assistants.
Twenty of the study participants (44.4%) had attended
any seminar or course on ethics in the past while ten
(22.2%) had received training specifically on research
ethics. The training were however for short periods – six
of the ten who received training in research ethics
attended a one day training, two attended a one week
training and the remaining two attended a six month
training course.
Demographic details of phase three study participants
Thirty biomedical researchers participated in the final
evaluation and this group included fifteen participantsfrom the first 45. The group comprised eighteen females
and twelve males with a mean age of 34.64 years (SD
4.28) and a range of 25.5 to 45.5 years. The demographic
details are as shown in Table 2. Eighteen of them were
resident doctors while the rest consisted of five medical
officers, two consultants and five research assistants.
Accessibility and comprehensibility of the online module
on Nigerian code
All the participants agreed that the online module was
comprehensible and accessible. However 2 of the 45
(4.4%) study participants said that the module was not
easily comprehensible. The same pattern was noted for
accessibility as 43 indicated that it was very accessible
while 2 (4.4%) noted that it was difficult to access. The
major challenges of these 2 participants were slow inter-
net speed, irregular power supply and arduous registra-
tion procedure.
Twenty three (51.1%) of the 45 completed the online
module within 45 minutes while thirty five (77.8%) of
the participants completed the module within an hour.
Most of 45 participants (97.8%) agreed that the module
improved their understanding of the conduct of research
in Nigeria. Two participants (4.4%) were not sure if they
would recommend the module to someone else.
The responses of the study participants on ways to im-
prove the comprehensibility and accessibility of the
module are outlined in Table 3. Forty-two (93.3%) of the
respondents suggested that comprehensibility can be
improved by increasing awareness of the Nigerian Code
among Nigerian biomedical researchers through organi-
zation of seminars, distribution of the hardcopies of the
Code and the addition of the Code to undergraduate
medical curriculum. Twenty (44.4%) of the respondents
indicated that accessibility to the module can be im-
proved by introducing the module as a course in tertiary
institutions and providing an access link on the Federal
Ministry of Health website.
Test performance of participants
All the 45 participants completed the pre-test and post-
test for the initial evaluation. The mean time taken to
study the online module was 49.8 (SD 15.7) minutes.
The mean pre-test score was 53.9 (SD 26.4) and mean
post-test score was 83.6 (SD 12.5) which was statistically
significantly different (p = 0.001) – Figure 1. The age of
the participants did not significantly affect the pre- and
post-test scores (p = 0.66). Likewise the sex of the study
participants did not affect their scores. The mean pretest
scores of the male (N = 27) and female (N = 18) partici-
pants were 58.8 ± 28.6 and 57.5 ± 30.9 respectively
(p = 0.89) while the means of the posttest scores were
82.2 ± 13.5 and 86.8 ± 8.3 respectively (p = 0.20). The
specialty of the study participants did not affect their
Table 1 Demographic data of study participants for phase 2 evaluation





21 – 30 2 4.4
31 – 40 39 86.7
41 – 50 4 8.9
Positions
Consultant/Clinicians 9 20.0
Senior Resident Docs 15 33.3
Medical Officers 9 20.0
Pharmacists 2 4.4
Research Assistants 4 8.9
Others 6 13.4
Specialty
Dental Surgery 2 4.4
Family Medicine 3 6.7
Internal Medicine 23 51.1
Pharmacy 2 4.4
Obstetrics/Gynecology 3 6.7
Public Health 5 11.1





University of Benin 3 6.7
Irrua Specialist 1 2.2
NAUTH Nnewi 2 4.4
NNPC Medicals 1 2.2
IHVN 4 8.9
State HMB 3 6.7
(Internal medicine specialty includes clinical pharmacology, dermatology, endocrinology, gastroenterology, nephrology and pulmonology).
UBTH University of Benin Teaching Hospital, NAUTH Nnamdi Azikiwe University Teaching Hospital, NNPC Nigerian National Petroleum Company, IHVN Institute of
Human Virology in Nigeria, HMB Health Management Board, PMTCT Perinatal Mother To Child Transmission.
Ogunrin et al. BMC Medical Ethics 2013, 14:1 Page 5 of 17
http://www.biomedcentral.com/1472-6939/14/1performances on the evaluation of the online module
(p = 0.95). The duration of time taken to complete the
pre- and post-tests (p = 0.47) and attendance at any re-
search ethics course (p = 0.23) did not affect their scores.
Analysis of the scores of the 30 participants who evalu-
ated the modified version of the module showed a mean
pre-test score of 49.3 (SD 21.2) and mean post-test score
of 86.0 (SD 11.3) which was statistically significant
(p = 0.001) – Figure 2. The age of the participants did not
significantly affect the pre- and post-test scores (p = 0.62).
Likewise the sex of the study participants did not affect
the pretest and posttest scores. The mean pretest scores of
the male (N = 12) and female (N = 18) participants were50.6 ± 20.5 and 47.9 ± 22.6 (p = 0.74) while the means of
the posttest scores were 83.1 ± 13.5 and 89.3 ± 7.3 respec-
tively (p = 0.12). The specialty of the study participants did
not affect their performances on the final evaluation of the
online module with p values of 0.33 and 0.58 for the pre
and post-test scores respectively. The duration of time
taken to complete the pre- and post-tests (p = 0.58) and
attendance at any research ethics course (p = 0.37) did not
affect their scores.
Correlation analysis and reliability testing
The correlation analysis of the pretest scores obtained
for the initial and final evaluation of the online module
Table 2 Demographic data of study participants for phase 3 evaluation





21 – 30 1 3.3
31 – 40 26 86.7
41 – 50 3 10.0
Positions
Consultant/Clinicians 2 6.6
Senior Resident 18 60.00
Medical Officers 5 16.7
Research Assistants 5 16.7
Specialty
Internal Medicine 5 16.6
Public Health 14 46.9
HIV/AIDS research 2 6.6




University of Benin 2 6.7
IHVN 11 36.6
(Internal medicine specialty includes clinical pharmacology, nephrology, neurology and pulmonology).
UBTH University of Benin Teaching Hospital, IHVN Institute of Human Virology in Nigeria, PMTCT Perinatal Mother To Child Transmission.
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yielded a coefficient of 0.8. These coefficients signified
excellent correlation between the scores obtained for
both the initial and final evaluations of the online mo-
dule. The test-retest reliability of the test performance
on the online module of the Nigerian Code was esti-
mated using the Cronbach’s alpha, a measure of internal
consistency of an instrument, by comparing the pretest
scores of the initial and final evaluation, and the posttest
scores for both evaluations. Values above 0.8 signify
acceptable reliability index. The Pretest reliability index
was 0.9 while the posttest reliability index was 0.8. The
internal consistency of the module as instrument to as-
sess the knowledge of the participants is highly indica-
tive of excellent test-retest reliability index.
Discussion
This study showed the utility of an online module based
on Nigerian Code of Health Research Ethics in improv-
ing the knowledge of ethical conduct of research among
the study participants as demonstrated by significantly
improved scores, satisfactory accessibility and compre-
hensibility, and excellent internal consistency. The reli-
ability of test instruments is paramount to its utility. An
instrument that lacks internal consistency and test-retestreliability is less likely to be effective. The ability of the
pretests and posttests on the online module of the
Nigerian Code to measure the knowledge obtained from
studying the module in a consistent manner is remark-
able and compared favorably well with a previous study
that validated a new tool for assessment of research eth-
ics knowledge and obtained Cronbach’s alpha of 0.8 [23].
This suggests that the module can be effectively used as
a tool for ethics training on Nigerian Code for all
researchers conducting biomedical research in Nigeria.
This is important for a developing country like Nigeria
where ethics capacity is inadequate and the teaching of
research ethics is still in its infancy. It is pertinent to
stress that the module emphasized the peculiarities of
ethical regulations that administrate human subjects’
research in Nigeria hence its focus was not on bioethics
as a whole. Therefore it should be used in conjunction
with other bioethics and GCP modules. This was the
advantage of uploading it onto the CITI website as CITI
provides other modules that cover general bioethics
training.
A recent randomized study that compared the impact
and acceptability of online and onsite methods of train-
ing in research ethics and statistics showed that both
methods led to marked and similar improvements of
Table 3 Suggestions on how to improve accessibility and comprehensibility of the online module based on Nigerian
code for health research ethics
Item Suggestions to improve comprehensibility Frequency of respondents
1. Design programs and training to create awareness about the Code 26
2. Provide hardcopies of Nigerian Code for researchers 16
3. Add to the curriculum for undergraduate education in Nigeria and make bioethics a core undergraduate course 10
4. Module is voluminous and so should be shortened 6
5. Highlight key issues and definitive statements of interest 4
6. Add more examples and illustrations including pictorial presentations 4
7. Add more information on roles of PIs 4
8. Make webpage more friendly 2
9. Include case scenarios in the module 2
Item Suggestions to improve accessibility Frequency of respondents
1. Adequate internet connectivity 12
2. Recommend the module for tertiary institutions in Nigeria 10
3. Provides link for the module on Federal Ministry of Health website 6
4. Make the log in procedure easier for researchers 5
5. Develop a separate website for training on the Nigerian Code 4
6. Encourage computer literacy 2
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demands and cost-effectiveness made the online method
more useful for expanding health research capacity in
resource-limited settings [24].
For online trainings, a basic requirement is the avail-
ability of internet services. Internet usage has been
growing in sub-Saharan Africa in the past decade espe-
cially for educational purposes. In Nigeria, all major
cities have internet services however quality, bandwidth
and consistency is low. Online trainings therefore have
to take this into account by avoiding use of media-heavy
web pages that require high bandwidth. It is also neces-
sary to ensure web pages resume from previous location
in event of service disruption, all of which were factored
into the design of this online course.
Furthermore, its access is not limited by subscription
as registration on the CITI website is free. The module
can be accessed through the West African Bioethics Pro-
gram institutional portal on the CITI website (www.
bioethicscenter.net). This portal is freely accessible to all
West African researchers and students. Access to the
module would be further enhanced with its inclusion on
the website of the Federal Ministry of Health of Nigeria
as suggested by some of the research participants. The
module has been endorsed by the National Health
Research Ethics Committee and its timely update is the
responsibility of the NHREC. An endorsed certificate of
completion is issued by the Director of the West African
Bioethics Training Program on successful completion of
the online module. The certificate is sent via electronic
mail to the researcher or student.The most effective way of delivery of ethics education
has not yet being clearly identified [25,26] but ethics
workshops and conferences have been held in different
parts of Africa [8] and there are clinical fellowships on
ethics training available in Canada and the United States
[27]. One of the suggestions obtained in this study is the
inclusion of ethics training in the undergraduate medical
curriculum. This is important because ethics education
prepares students to address ethical challenges [28], and
this multi-faceted formal ethics teaching equip students
with a common framework on which to reconcile
patients’ medical needs with their values, perceptions,
situations and beliefs. It has been noted that the univer-
sity setting provides an excellent environment for dis-
cussions of the principles behind moral reasoning [29].
This is a plausible idea but the shortage of trained
bioethicists [8] in sub-Saharan developing nations mili-
tates against this.
Now is the time to bridge the ‘ethics education gap’
between the developed and developing countries and
resolve the ‘knowledge gap’ in bioethics among research-
ers in developing countries especially with the increasing
trend of multi-national scientific collaborations and con-
duct of clinical trials in developing countries. This online
training tool would therefore serve to orient national
and international biomedical researchers working in
Nigeria on cultural and societal relevant ethical princi-
ples. It is hoped that the knowledge of ethical require-
ments obtained by studying this module would translate
into conduct of ethically acceptable biomedical research













Box graph showing relationship between pre and post test scores
pretest score posttest score
Figure 1 Box Plot showing pretest and posttest scores on
initial evaluation of the Module.
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knowledge and practice of ethical guidelines learnt from
the online module among the participants to determine
medium and long-term benefits.Conclusions
This study has shown that the online module based on
the Nigerian Code of Health Research Ethics can be uti-
lized effectively for online ethics education. The perfor-






Pretest and Posttest scores on final evaluation of module
pretest2 postest2
Figure 2 Box Plot showing the Pretest and Posttest scores on
final evaluation of online module.on testing after studying the module and the test instru-
ment demonstrated a high internal consistency. As bio-
ethics is being integrated into healthcare settings more
widely and systematically, training in bioethics becomes
equally important. Online ethics training has gained
wide acceptability and many biomedical researchers all
over the world had received training in research ethics
with the CITI. The addition of this online module to the
CITI would ensure accessibility of the Nigerian Code to
biomedical researchers interested in doing multi-
national research in Nigeria as they study other general
bioethics modules on the CITI website, and this in turn
will facilitate understanding of particularities of ethical
requirements in Nigeria. The final version is online for
ethics training at www.citiprogram.org.
Appendix A. Annex 1
Introduction
All institutions in Nigeria involved in conduct of health
research must have a registered health research ethics
committee. (See Section C, pp. 16 of the National Code
for Health Research Ethics of Nigeria, 2007 and Appen-
dix 1 Section 34 (1) pp. 59 of the National Health Bill
passed by the Nigerian National Assembly (Senate) on
15th May 2008).
Functions of HRECs
Apart from the functions of an ethics review committee
which have been covered in other parts of this training
program, when a researcher in an institution is conducting
research at a location very far from his primary place of
employment, he/she will need to find a co-investigator in
an institution near the research site and obtain ethical ap-
proval from the institution there. For example, a Nigerian
researcher who is conducting research in Ghana or
Cameroun needs to find a local collaborator and obtain
ethical approval from the local institution. The rationale
for this is that ethical review of research must be sensitive
to local conditions, culture and traditions which only a
properly constituted ethics committee in that locality is
best positioned to understand and bring to bear on the re-
search process. Furthermore, local authorities must have
easy access to a member of the research team in case con-
cerns arise with the conduct of the research.
In Nigeria, an institution may propose to have more
than one research ethics committee but the jurisdiction
of each must be clearly defined so that there is no over-
lap. For example, an institution may have one ethics
committee for biomedical research, another for social
and behavioral sciences research and yet another for ani-
mal research. Transparent and open channels of com-
munication between these multiple ethics committees
must be put in place so that there is no “ethics commit-
tee shopping” by members of staff. Researchers in
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not submit the same protocol to more than one ethics
committee within the same institution either simultan-
eously or sequentially. Of course, this does not include
situations where a particular committee decides that the
protocol is best reviewed by another committee and
refers the researchers appropriately. (See Section C, sub-
sections c & d, pp. 19 of the National Code for Health
Research Ethics in Nigeria).
Registration of Ethics Committees
In contrast to the practice in many other parts of the
world, the regulation in Nigeria requires that ethics
committees be registered with the National Health Re-
search Ethics Committee. (See Section C, pp.16 of the
National Code for health Research Ethics in Nigeria).
The objective of this registration is to ensure that all
ethics committees in Nigeria adhere to a minimum
standard of composition, management and function, and
that they adhere to the tenets of the National Code. A
list of all currently approved ethics committees is on the
website of NHREC (available at http://www.nhrec.net/).
The list contains the names of the institutions, the prin-
cipal officers of the committees, their contact informa-
tion, category that the ethics committee falls into and
when the registration will expire. Ethics committees are
registered for two years only after which the insti-
tution shall apply for re-registration. The re-registra-
tion application must be submitted to the NHREC
within the last six months of the expiry of the current
registration.
Requirements for initial registration
An ethics committee shall be eligible for registration af-
ter fulfilling the following requirements:
Submission of an application package which includes:
○ A letter from the authorized head of the institution
or his designee stressing that the line of reporting of
the Chairman of the institutional ethics committee is
directly to the Chief Executive of the institution. This
confers sufficient power on the ethics committee
chairman and averts or forestalls undue pressure on
the committee in event of disapproval of research
protocols,
○ Provision of a list of members of the proposed ethics
committee indicating names, qualifications, what
profession or status (scientist, non-scientist, lay
person, community representative, religious
affiliation, gender etc.) they are representing,
research review experience of the committee,
evidence of completion of NHREC approved
research ethics training and any other informationthat may be construed as conflict of interest on the
part of members of the committee;
○ Submission of a statement of agreement to comply
with the National Code and,
○ Commitment to provide office and storage space for
the committee.
The guidelines for membership selection are similar
to those enumerated in international guidelines and
documents. Note however that in common with many
developing countries, Nigeria is a multi-ethnic, multi-
religious society where attention to cultural and
religious sensibilities is critically important. (Section
C, pp. 16 of the National Code for Health Research
Ethics).
Requirements for re-registration
An institution seeking re-registration for its ethics com-
mittee must provide:
 A current list of members, Report of fulfillment of
previously stated commitment to provide
infrastructure and logistics support for the
committee, Complete record of the activities of the
committee (including financial records, statutory
meetings, complaints and litigations, details of
protocols received and their outcomes and the mean
time from protocol submission to approval) for the
outgoing year.
What happens if an institution fails to re-register?
The ethics committee is de-registered by the NHREC
and the institution has to apply anew. During this period,
no research may be conducted in the institution.
Conducting research in institutions without ethics com-
mittee (See Section C, sub-section f, pp. 10–11 of the Na-
tional Code for Health Research Ethics in Nigeria)
In a situation where it is necessary to conduct research
in a Nigerian institution or center without ethics com-
mittee, there are several options that the researchers
may pursue. These include:
 The institution without ethics committee may
establish a cooperative agreement with a
registered ethics committee located within the
same state as the institution or in the event of
none in the state, within the same geo-political
zone of the country, to review the research. This
agreement must be submitted to NHREC for
approval and its duration shall not be longer than
the registration period of the reviewing ethics
committee.
 The researcher may also submit the proposal to
NHREC for review. NHREC may review the
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shall learn about later in this module.
Functions and operations of HREC
The main objective of institutional ethics committees is
the protection of research participants in Nigeria from
egregious harm by enforcing compliance with the ethical
guidelines in the Code, the clinical trial agreement and
material transfer agreement (see below under CTA and
MTA). The ethic committees also protect the right of
researchers to publish their findings and ensure that they
are not exploited or put under undue pressure by spon-
sors, institutions, participants or communities taking
part in research. The committee may demand an agree-
ment, before ethical approval is given, indicating owner-
ship and rights of access to data, resources, intellectual
property and infrastructure generated in the course of
the research at the pre-research stage to protect the
right of researchers to publish their findings and avert
future exploitation of the researchers (See Section E,
sub-section r, pp. 36–37 of the National Code for Health
Research Ethics in Nigeria).
The review process of research protocols
The review process of research protocols entails the fol-
lowing: (the details of which is available at Section E, pp.
24 of the National Code for Health Research Ethics in
Nigeria)
 Shall be conducted at regularly convened ordinary
meetings of the institutional ethics committee
with simple majority of members present,
including at least a member whose primary
concerns are in non-scientific areas, except of
protocols that require expedited review. In other
words, there is no indication for emergency
review of protocols with the risk of abuse.
Members can participate by phone, video
conference or VOIP.
 The ethics committee is expected to complete
review of any protocol sent to it within 3 months
of receipt otherwise the applicant may complain
to the national ethics committee of delay. This
provision serves to prevent undue delay in
granting approval and commencement of
research. Ethics committee that repeatedly delay
processing of protocols may find their category
downgraded with resultant loss in the types of
protocols and research that can be conducted in
their institutions.
A researcher may be requested by the ethics
committee to pay fees commensurate with the
requirements for adequate oversight of research
(depending on the size, complexity, duration, statusof researcher and sponsor of research)
and for any other of its activities at the discretion
of the Ethics Committee. Fees can be set only after
due consultation with the principal officers of the
institution where the ethics committee is located.
 The committee also performs oversight functions
for the studies that it has approved to ensure
that all stakeholders in research perform their
responsibilities.
Requirements for conduct of research
Research submitted to the ethics committee can only be
registered as being properly submitted and accepted for
review by the Ethics committee if a complete set of all
required documentation has been provided. The mini-
mum requirements are:
 A copy of the research protocol and all materials
needed for the consent process. This may include
consent form – with translations if necessary,
information sheets, radio jingles and video for
advertisements, etc.
 Evidence of completion of recognized informed
consent training and that of key co-investigators
undertaken within two years of the date of
submission of application for ethical review of
protocol to HREC.
 Brief curriculum vitae (2-3pages) of the principal
investigator so that the committee can ascertain his/
her qualification to carry out the proposed research.
 Where relevant, copies of letters from co-
investigators, laboratories and sources of resources
that may be required for the implementation of the
project.
 Evidence of sponsorship, where the research is being
sponsored by organizations, etc.
 A one page plain language summary of the proposed
research
 Copies of all questionnaires, case report forms and
instruments to be used in the research.
 Samples of drugs, placebos, medical devices etc.
such as may be necessary for the ethics committee
to make a decision.
 Decisions of other ethic committees where this is
available, for example in multi-centered research
 Copies of all agreements, for example Materials
Transfer Agreement (see Section E, sub-section n,
pp. 33–34 of the National Code for Health Research
Ethics in Nigeria), Clinical Trials Agreement (see
section E, of the National Code for Health Research
Ethics in Nigeria), Insurance certificates, etc.
(Further details are available in the National Code
for Health Research Ethics in Nigeria, Section K,
sub-section f, pp51-52.)
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required to submit an annual report containing a brief
summary statistics of the research (number of research
participants, number of adverse events, complaints and
their resolutions) to the supervising HREC within three
months of expiry of the current research approval.
Informed consent
Informed consent is an integral part of the ethical con-
duct of research in Nigeria. All researchers are expected
to design a consent process appropriate for the type and
context of their research, the expected participants and
risks anticipated (See Appendix 1, Section 32, pp. 57 of
the National Code for Health Research Ethics).Where
consent forms are used, such consent forms must not be
longer than 8 pages, typed in double spacing with Times
New Roman size 12 font. This is to enhance legibility
and prevent researchers from squeezing information into
forms. The contents of the consent form should not be
beyond the reading ability of a Nigerian Junior Secon-
dary graduate (that is 9 years of formal education) so
that participants can understand and recall the contents.
The consent form shall contain the following essentially
in this order (See Section F, subsection f, pp. 41of the
National Code for Health Research Ethics in Nigeria):
 Title of research, Names and addresses of the
researchers and sponsors (including telephone, fax,
e-mail etc.), The reason for doing the research
 Estimated number of participants in the institution.
Where this is a multi-institutional research, the total
number of participants should also be stated.
Research participants tend to feel more confident if
they are part of a larger group than a small one.
 What research participants are expected to do; The
expected total duration of research – in months or
years. The duration of participants’ involvement. For
example, participants may be interviewed for 30
minutes and their blood samples taken; or
participants may be interviewed repeatedly over
several months for some years.
 The costs to the participants of participating n the
research, generally research should not cost
participants anything since those participating are
doing so out of sense of altruism.
 The risk of participating in the research. This must
be presented early in the consent process before
introducing information about benefits or
compensation so that potential participants are still
fresh and engaged when they are given the
opportunity to think about the risks that may be
involved consequent on their participation.
 The health benefits of participating in research are
mentioned next. In many epidemiological studies,particularly of the case–control variety, the cases
already have the condition of interest. They are
therefore not likely to derive any direct health
benefit from participating in the research. However,
these information generating researches may
improve knowledge about the disease that will
benefit others including the controls, family
members of cases and even the cases, if the disease
may recur in some other parts of their body. Where
there is no direct health benefit to participants, this
should be clearly stated in the consent form.
Compensation for lost wages, transport and
opportunity costs as determined by the researchers
in consultation with local experts or the ethics
committee should then be stated.
 It is sometimes appropriate to give participants
inducement in order to encourage their participation
in research. What is frowned upon is undue
inducement where the amount offered is so large that
participants are tempted to carry out actions that are
not in their best interest. Usually what constitutes due
inducement can be derived from local knowledge and
consultation with the ethics committee. With regards
to compensation and inducement, the specific
amount (or their equivalent in kind) involved should
be stated in the consent form.
 The consent form should state the measure that will
be used to protect the confidentiality of research
participants. This will vary with the sensitivity of the
information collected and the complexity of the
research.
 The consent form should state clearly and
unequivocally that participation in the research is
voluntary and include information about what will
happen to any individual who chooses not to
participate in the research. This usually requires a
statement of commitment to the individual that
the decision they make will not in any way affect
their care in the institution where the research is
being conducted. In some situations, the
participant may want to withdraw from the
research after participating in part or all of it.
The mode of dealing with requests for withdrawal
in such circumstances varies with the type of
research and the individual’s participation. In any
event, a clear statement of the modality for
orderly withdrawal from the research needs to be
included in the consent form.
 Some research participants may suffer injury during
participation in research. Because of this, the action(s)
to be taken in case of injury or adverse events should
be stated. In our environment, this usually requires
that the research team takes full responsibility for the
care of the research participant once it is established
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research.
 Increasingly, what happens to individuals or
communities when research is over is engaging the
attention of ethics committees. This is a complex
matter that requires extensive dialogue between
researchers, ethics committees, and representatives
of the community, the institution and other interest
groups. There is no single approach that works in all
situations that may arise in research, however
careful forethought and planning will avoid future
ethical dilemma.
 The consent process should also include adequate
disclosure of any apparent or potential conflicts of
interest as determined by the ethics committee
based on the prevailing norms.
Where written informed consent is not possible (See
Section F, sub-section f, p. 43 of the National Code for
Health Research Ethics in Nigeria)
In some circumstances, it is not possible to obtain a
written consent form. This includes situation where
research participants cannot read or are unable or
unwilling to read the consent form. In such situations,
acceptable options include translating the consent form
to local languages where the problem is inability to read
English language. In other situations, the participants
may be unable or unwilling to read even local languages,
in such situations, a witnessed thumb printing or wit-
nessed audio recording of the consent may be done.
Re-consenting
In some research situations, it may be necessary to
take consent more than once. This may be required
in situations where participants are being involved in
incrementally risky elements of research or in re-
search studies that are taking place over a long dur-
ation of time or where information comes to light in
the course of a research that changes the risk-benefit
analysis of the research project.
HREC records
Adequate documentation is expected from all registered
HRECs in Nigeria. This is particularly needful for the
purpose of inspection by the NHREC and if necessary by
other agencies through the NHREC, and also in case of
future litigation. Documentation of all its activities and
materials pertinent to research review which must be
kept include:
 Minutes of all meetings which shall contain
sufficient information on attendance of members at
meetings, actions taken by the ethics committee at
the various meetings and how decisions werereached including the vote on decisions, the number
of votes for and against and abstentions.
 Letters of complaints from applicants who
submitted protocol to the committee. And in event
of any change of decision in a proposal status, the
reasons for such a change, including the information
and/or data used to arrive at the new decision, must
be included in the minutes of the meeting at which
the decision was taken.
 A written summary of the discussion and how the
issues were resolved for issues that are controversial
and demanded extensive debates among members.
 All copies of research proposals received and
reviewed by the committee, including the reviews
from scientific and/or non-scientific experts. These
must include the dates proposals were submitted to
the committee and when the approvals were given.
This provides proof of non-delay in taking decisions
on proposals by the committee as it is expected to
take decisions within 3 months of receipt of
proposal.
 Copies of consent materials approved by the
committee (see details above - under ‘Informed
consent’)
 All progress reports submitted to the committee by
the researchers, institutions and sponsors and these
must include details of injuries and adverse events to
participants accrue to their participation during and
after the research
 All correspondences between the HREC and
researchers, sponsors, institutions and all other
agents consulted by the committee in the discharge
of its duties.
 Details of financial records showing income, direct
expenditure and other related expenses.
 Complete records of continuing oversight activities
of the HREC for all research protocols approved by
it during the period of report. (See Section K, pp
50–52 of the National Code of Health Research
Ethics).
Continuing ethics training and clinics
The Code emphasizes the importance of ethics training
and education, a function that may be performed by the
institutional HREC or by independent suitably qualified
individuals and organizations. Such training programs
are acceptable for membership of the HREC and consid-
ered adequate training in research ethics for protection
of human subjects if they:
1. Contain modules on Nigerian National Code of
health research ethics, principles of research ethics,
HREC functions, research integrity and misconduct,
research methodology and administration, and
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with ethical principles and guidelines, and avert non-
inclusion of NHREC-certified modules in the training
curriculum.
For the purpose of aiding researchers in the devel-
opment of their protocols and providing advisory sup-
port during the conduct of research, the HREC may
conduct ethics clinics and consultations for a fee at
its discretion and as it may determine. This function
should however be strictly separated from the HREC
oversight responsibility. In addition, suitably qualified
individuals or organizations may also offer ethics con-
sultancy services provided they are certified by the
NHREC to ensure that there is no departure from the
minimum standard expected from all stakeholders in re-
search. (See Sections G, H, I and J of the National Code
for Health Research Ethics).
Disciplinary action (see National Code for Health Research
Ethics, Section M pp. 54)
Disciplinary actions would be taken against any re-
searcher, institution or sponsor who is guilty of research
misconduct or violates the national code or institutional
guidelines. The HREC may recommend such party to
the NHREC for disciplinary action after:
 All steps for resolutions of problems in research
have been exhausted by the HREC, and
 The actions of the involved party have been fully
investigated and discussed at a regularly convened
meeting of the committee.
Such recommendation from the institutional ethics
committee must reach the NHREC within two weeks
following the HREC meeting where the decision was
taken. The recommendation must be accompanied by
detailed records of the misconduct. It is important to
note that if such misconducts are either clear violations
of civil and criminal law such as fraud or assault, or of
institutional rules, the HREC may report to the appro-
priate legal authorities or the researcher’s institution as
the case may be. The affected researcher, institution or
sponsor shall also be duly notified of the HREC decision.
NHREC may in addition take the following actions
against any researcher, institution or sponsor found
culpable:
 Advertises such cases of research misconducts
and report to other appropriate regulatory bodies,
and if such breach of ethical conduct involves
international collaborative research then the
matter is reported to the national regulatory
agency of the country of origin of the researcher.This action does not preclude the use of legal
action against such researcher or his/her
collaborators in Nigeria in accordance with the
law. For instance, cases of fraud, deception,
fabrication or plagiarism may be reported to the
police or other relevant authorities.
 The researcher may be barred from conducting
research in Nigeria for a specified period of time
based on the severity of his/her offence.
 NHREC may also recommend to institutions and
other relevant regulatory bodies penalties that would
be faced by researchers who are guilty of
misconduct.
 Depending on the case under consideration, the
researcher(s) may be required to make restitution to
research participants, institutions, sponsors,
communities or any other person as directed by the
NHREC. For instance, if a researcher is found guilty
of deception and fraud, he/she may have to make
public apology to the research participants or
community involved in research and/or pay back (in
cash) the amount involved to either the participants
or institution as the case may be and as determined
by the HREC or NHREC. In addition, he/she may
be barred from conducting research in Nigeria for a
period of time.
 In the event that an HREC is the offender, then the
HREC may be suspended for a variable period of
time based on the severity of offence.
NHREC oversight functions
The National Health Research Ethics Committee may
review research protocols:
 If it involves nationwide trial (more than 3 research
sites). For example the protocol of a trial to
determine the clinical efficacy of a drug that is being
introduced into the Nigerian market which is to be
tested among patients attending four tertiary health
facilities in different parts of the country requires
NHREC review; or
 If it is referred by an institutional ethics committee
either because the HREC is not qualified to review
or otherwise; or
 In cases of institutions where no ethics committee
exists and such institution has no cooperative
agreement with another HREC (as stated above
under Conducting research in institutions without
ethics committee); or
 If the NHREC so desires based on the complexity
of the protocol, the magnitude of risks and
existence of controversies like issues of standard
of care. The NHREC may achieve this by either
mandating an institutional ethics committee (thus
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that such committee takes over the oversight
function, or the NHREC may constitute itself into
a committee for the purpose thus retaining the
oversight function. (See Section L, pp. 53 of the
National Code for Health Research Ethics for
details)
The NHREC also reviews the annual report and regis-
tration status of the HRECs, and institutions’ commit-
ment to ensure proper functioning of the HRECs. It also
settles disputes arising from appropriate interpretation
of the Code as it is the NHREC that is responsible for
the update, revision and modification of the Code in ac-
cordance with new developments in international re-
search ethics.
In addition, the NHREC establishes the categories of
HRECs in the country on the basis of the following cri-
teria (See Section C, subsection g, pp. 20 and Appendix
1, Section 34, pp. 59–60 of the National Code of health
Research Ethics):
 Size of the committee and the qualifications,
training and experience of its members in research
ethics and science. The more qualified and
experienced the members of a committee are, the
higher the rating accorded the HREC by the
NHREC. This criterion is not taken in isolation but
with others stated below.
 History of the committee vis-à-vis its past review
activities from records submitted by the HREC to
the NHREC, the period that the committee has
been in existence, how good its record keeping has
been and the level of its compliance with the
National Code.
 The amount of resources at the disposal of the
committee and the affiliated institution i.e.
supporting personnel, infrastructure and finances.
These criteria are clearly outlined from time to time
so that all HRECs are aware of the pre-requisites for
rating them by the NHREC at the latter’s regularly
scheduled meetings. Each category of HREC in
Nigeria shall be assigned the types of research it can
review. This implies that some HRECs may not be
qualified to review some research protocols based on
their categorization by the NHREC. Such protocols
may be reviewed by qualified HREC within the same
institution or same geo-political zone or by the
NHREC.
There are two important agreements that ensure ade-
quate protection of research participants and the re-
search staff in Nigeria. These are clinical trial and
material transfer agreements.What is the clinical trial agreement (CTA)?
 It is a contract and agreement between a research
sponsor and the principal investigator (PI) of a
clinical trial enforcing compliance with all ethical
regulations governing conduct of research in Nigeria.
This agreement is signed by the PI, the research
sponsor and head of institution (i.e. where the ethics
committee reviewing the protocol is sited).
 It is a statement of commitment made by the
principal investigator to conduct trial in compliance
with the National Code and the ICH-GCP
(Available at http://www.ich.org/ ), and/or ISO
14155 for trials of medical devices and also in
compliance with guidelines from relevant oversight
and regulatory agencies, institutional guidelines and
Federal Ministry of Health requirements.
 This agreement also demands that the principal
investigator and his/her institution where the
ethical approval is obtained will cooperate fairly
and appropriately in the event of legal claim
relating to the conduct of trial. This implies that
there shall be amicable resolution of issues arising
from the research, for instance the institution
may assist in the care of research participants
who suffer some form of injury or adverse event
in the course of experimentation, or in the event
of litigation from community participants, and
not leave the researcher alone to carry the
responsibility,
 In the event that the research sponsor is the PI,
then he/she must include in the agreement the
estimated cost of and sources of funds for the trial,
the number of participants, and a complete budget
of the trial and the dates of payments.
What is the material transfer agreement (MTA)?
 It is a mandatory agreement that is required if a
research involves the transfer of samples and
biological materials such as animals, herbs and
plants out of Nigeria and it must be signed by all
parties involved in the research including the local
and international investigators, heads of local
institutions, and research sponsors. The rationale for
this agreement is to protect the (a) local researchers
and Nigeria’s human and natural resources in all its
biodiversity, (b) community participants in research
and (c) the nation from exploitation and harm.
 The agreement must contain the details and
conditions for the transfer of the samples such as:
(a) The type of materials that is to be transferred and
its anticipated use, (b) The locations and duration of
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mitations to the use of such materials and when its use
will be terminated.
 The MTA must be reviewed by the HREC to
ensure that it conforms to the objectives of the
research and contents of the informed consent.
The institutional REC may grant provisional
approval for transfer of samples pending the
submission of both the MTA and provisional
approval of the HREC to the NHREC who will
acknowledge its receipt for record purposes only.
It is the responsibility of the researcher to inform
the institutional HREC of the NHREC’s
acknowledgement of receipt of the MTA. This
prevents undue delay in the commencement of
research but this does not preclude withdrawal of
approval by the HREC or the right of participants
or communities from whom samples are obtained
to withdraw them according to terms of the
informed consent process. Thus ensuring the
preservation of their autonomy and demonstration
of respect for persons in research.
 The institutional HREC has the responsibility
to grant final approval to research involving the
transfer of research samples out of Nigeria.
But such approval can only be given if all the
other criteria as stated in the National Code
or institutional guidelines have been met and
the NHREC has acknowledged receipt of the
MTA.
 In the event that the NHREC fails to acknowledge
receipt of the MTA in 2 weeks and there is a
verifiable proof that the applicant has sent same to
the NHREC, then the institutional REC can issue
the final approval for the research.
 If the researcher or PI makes any amendment to the
MTA, he/she is expected to submit a request for
amendment of protocol to the institutional HREC
and the HREC shall review it in the usual manner as
for protocol amendment at its regularly convened
meeting.
(See details at Section E, subsection n, pp 33–34 of
the National Code for Health Research Ethics).Other Nigerian regulatory agencies in research
The conduct of clinical trials in Nigeria requires the
approval of other regulatory agencies apart from the
institutional ethics committee. There are four regula-
tory agencies specified in the National Code that con-
tribute to protection of research participants from
harm and ensure conduct of trials at the highest eth-
ical standard.National Agency for Food and Drug Administration and
Control (NAFDAC)
 This agency gives permission for the conduct of
clinical trials to test the efficacy and safety of new
finished products for sale or use as food or drugs in
Nigeria.
 Such clinical trials that would be conducted in
Nigeria must however conform to the guidelines
issued by National Health Ethics Research
Committee and other regulatory bodies.
Institutional Bio-safety committees (IBC)
 The IBC provides bio-safety review of research
involving the use of classified hazardous substances
of physical or biological nature (like pathogens,
radioactive materials, application of recombinant
DNA techniques and processes etc.) with the overall
objective of minimizing potential human and
environmental risks.
 It is made up of a bio-safety officer and at least
three other officers with appropriate expertise, and
is established by the institution where research is
conducted and registered with the NHREC (see
NHREC oversight functions above)
 The IBC ensures that the researcher provides safe
and suitable storage for materials used for research
and also ensures that research staff has adequate
training in bio-safety.
Data and Safety Monitoring Boards (DSMB)
Data and Safety Monitoring Boards (DSMB) – is an in-
dependent group of experts (comprising individuals with
appropriate training and scientific knowledge in all
aspects of research with adequate medical, pharmaceu-
tical, scientific, bio-statistical and clinical trial experience
as well as ethics qualifications) assembled before the
commencement of research by the study sponsors to
review safety data during the clinical trial.
At least three of the members must be independent of
the clinical trial and sponsor. This is to avert or prevent
conflicts of interests and allow for unbiased assessment
of safety data.
All drug efficacy trials and clinical trials in Nigeria are
expected to have a safety monitoring plan implemented
through the DSMB to ensure safety of study participants
and preserve the integrity and credibility of the research.
Community Advisory Board (CAB)
This committee is established by the study investigators
on the recommendation of the institution or the ethics
committee supervising the trial depending on the nature
and site of research. The role of community ‘gatekeepers’
Ogunrin et al. BMC Medical Ethics 2013, 14:1 Page 16 of 17
http://www.biomedcentral.com/1472-6939/14/1in the successful implementation of research in Nigeria
underscores the importance of the CAB. The multi-ethnic,
cultural and religious diversities of the Nigerian nation
and its influence on ethical issues in research demand
community participation from the pre-research stage to
avoid conflicts and frictions during and after the research.
The CAB consists of members, from the communities
where trials are to be conducted, who are selected
through the usual consultative process with the commu-
nity (for example religious leaders, persons who under-
stand local laws and cultural values including gender
issues, representative of study population, and commu-
nity leaders) and some members of the research team
(usually not more than 20% of the total membership).
The CAB plays crucial roles in assisting researchers
conducting trials in Nigeria to understand and incorpo-
rate community concerns into their research plans and
activities. It provides information on traditional beliefs;
advises on effective methods of information dissemin-
ation, recruitment and retention of study participants
and may assist in the resolution of ethical problems
that arise during and after research (See Section E,
subsection r, pp. 37–38 of the National Code of Health
Research Ethics).Furthermore, the CAB offers the com-
munity members to air their views on ethical issues
relating to the proposed research as they affect indi-
vidual members, the community as a whole, and pos-
sibly neighboring communities and the nation. The
Board also serves as s forum for disseminating pre,
intra and post research information to members of the
community.
(details of the Nigerian Code of Health Research Ethics
can be accessed at www.nhrec.net).
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